WH
William K Heiden
Director

William K Heiden insider trades: Macrogenics (MGNX) stock buys and sales

Director, Macrogenics Last trade Aug 20, 2025 53 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2015
4
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where William reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 20, 2025MGNX↑ Buy$151K
Nov 10, 2023ATRA↑ Buy$25K
May 9, 2019AMAG↑ Buy$107K
Aug 7, 2018AMAG↓ Sell$125K
Jun 4, 2018AMAG↓ Sell$500K
Oct 1, 2015AMAG↓ Sell$79K
Sep 1, 2015AMAG↓ Sell$122K
Aug 3, 2015AMAG↓ Sell$129K
Jul 15, 2015AMAG↓ Sell$1.5M
Jul 1, 2015AMAG↓ Sell$139K
Jun 5, 2015AMAG↓ Sell$4.7M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MGNX insiders

Open-market trades in the last 12 months

About William K Heiden's insider trades

William K Heiden is a director at Macrogenics (MGNX). Since Jun 5, 2015, William has reported 3 open-market purchases worth $283K and 8 sales worth $7.3M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (29 filings), shares withheld for taxes (12 filings), option exercises (7 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MGNX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.